# FDA Inspection 1103304 - LifeSan Clinical Research - August 08, 2019

Source: https://www.keypedia.com/records/fda_inspections/lifesan-clinical-research/4cf176e5-0749-4338-852f-e0e89d06f626
Source feed: FDA_Inspections

> FDA Inspection 1103304 for LifeSan Clinical Research on August 08, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1103304
- Company Name: LifeSan Clinical Research
- Inspection Date: 2019-08-08
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1203658 - 2023-02-24](https://www.keypedia.com/records/fda_inspections/lifesan-clinical-research/6ab4d7d6-c636-4b24-ba18-936b70b425b5)
- [FDA Inspection 1194075 - 2022-12-09](https://www.keypedia.com/records/fda_inspections/lifesan-clinical-research/4bf57e37-0d93-4e12-94cb-c6151134fa28)
- [FDA Inspection 1105189 - 2019-08-30](https://www.keypedia.com/records/fda_inspections/lifesan-clinical-research/5217f92d-0b50-428d-925a-37d41d63eca6)

Company: https://www.keypedia.com/companies/lifesan-clinical-research/0dd80557-7500-4efc-b99c-4b213eed12ac

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c